Title : Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells.

Pub. Date : 2022 May 4

PMID : 35247917






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells. BAY-876 solute carrier family 2 member 1 Homo sapiens
2 DBI-1 and the GLUT1 inhibitor, BAY-876, synergistically inhibit CRC cell growth in vitro and in vivo. BAY-876 solute carrier family 2 member 1 Homo sapiens